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A B S T R A C T   
Background: Setaria megaphylla (Steud) Dur & Schinz (Poaceae), a grass used ethnomedically by herbalists in 
Nigeria for the treatment of diabetes was evaluated for antidiabetic, hypolipidemic and pancreas protective 
potentials in rats. 
Methods: Solvents fractions (hexane, dichloromethane (DCM), ethyl acetate (EA) and methanol ) were investi-
gated for antidiabetic, hypolipidemic and pancreas protective potentials in alloxan-induced diabetic rats. Gli-
benclamide was used as positive control. The fasting blood glucose (FBG) level, serum insulin, glycosylated 
hemoglobin (Hb1Ac), oral glucose tolerance test (OGTT) and lipids levels were determined. Histopathological 
study of the pancreas was done. Isolation of phytochemicals and their subsequent identification using Fourier 
transform infrared spectroscopy, gas chromatography-mass spectrometry and nuclear magnetic resonance 
spectroscopy were carried out. 
Results: Treatment of alloxan-induced diabetic rats with the leaf fractions caused significant (p < 0.05–0.001) 
reduction in FBG of treated diabetic rats in acute and prolonged studies as well as OGTT with DCM, EA and 
hexane fractions having pronounced activities. The leaf fractions also caused significant (p < 0.01) decreases in 
Hb1Ac levels and increases in serum insulin levels. The leaf fractions further caused lowering of serum total 
cholesterol, triglycerides, low density lipoprotein (LDL), very low density lipoprotein (VLDL) with increased high 
density lipoprotein (HDL) level in the treated diabetic rats. Histopathological study of pancreas revealed pro-
tective effect by the leaf fractions. 1-Triacontanal, 1-triacontanol, 1-dotriacontanol, 1-triacontyl cerotate, and 
stigmasterol were isolated and identified from the active DCM and EA fractions of this plant for the first time . 
Conclusion: The leaf fractions of S.megaphylla possess hypoglycemic, insulin secretion stimulatory, hypolipidemic, 
and pancreas protective potentials which may be due to the activities of the phytochemical constituents.    
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Introduction 
Diabetes mellitus (DM) is a chronic metabolic disease affecting 
economic and social activities of all countries of the world with esti-
mated millions of deaths worldwide due to high blood glucose and risks 
of associated complications, which often result in premature death 
(WHO, 2017). There are three major types of DM: type 1 diabetes 
(T1DM, insulin dependent), type 2 diabetes mellitus (T2DM), and 
gestational diabetes mellitus. T2DM contributes to more than 90% of all 
DM cases. According to International Diabetes Federation in 2019, the 
total adult population stands at 463 million with diabetes, which may 
increase to 578 million and 700 million by 2030 and 2045, respectively 
(Saeedi et al., 2019). The increasing prevalence of diabetes is worrisome 
and calls for an urgent remedial steps as the orthodox medicines used in 
the management of DM seem to be inadequate and challenging (Saeedi 
et al., 2019). The current use of orthodox drugs and insulin in the 
management of diabetes does not offer satisfactory treatment outcome 
as the drugs are associated with unpleasant side effects such as hypo-
glycemia, hypersensitivity, gastrointestinal disturbances, hepatotoxici-
ty, renotoxicity and heart failure ((Basu et al., 2015); Sudasinghe and 
Peiris,2018). Herbal preparations are highly patronized for the man-
agement of diabetes due to their low cost, accessibility, relative safety 
and many biological activities compared to conventional anti-diabetic 
drugs (Badri et al., 2006; Khan et al., 2012; Peiris et al., 2015). Medic-
inal plants have been extensively investigated for the potential treat-
ment of DM (Marles and Farnsworth, 1995; Ezuruike and Prieto, 2014; 
Tran et al., 2020). Various phytochemicals such as ginsenosides in Panax 
ginseng, cucurbitane type terpene glycosides in Momordica charantia, 
glycyrrhizin in Glycyrrhiza glabra and berberines in Coptis chinensis have 
been found to possess antidiabetic activity (Park and Jang, 2017). In 
particular, metformin, one of the most common drugs for DM, is derived 
from guanidine compounds in Galega officinalis (Bailey, 2004). Hence 
there is the need to search for new antidiabetic compounds from me-
dicinal plants with potentials to circumvent the present challenges faced 
in DM management. 
Setaria megaphylla (Steud) Dur & Schinz (Poaceae) is a perennial 
pasture grass distributed widely in tropical and subtropical countries of 
the world (Van Oudtshoorn, 1999). It is called ‘nkwongo’ in ibibio or 
broad leafed brittle grass. Although no detailed ethnopharmacological 
survey has been carried out on medicinal plants used by the Ibibios in 
Akwa Ibom State, reports of ethnomedicinal use of the plant (leaves and 
roots) by herbalists from Ibibio tribe in Niger Delta region of Nigeria for 
the treatment of diabetes have been published (Okokon et al., 2006; 
Okokon and Antia, 2007, 2007a). Preliminary reports indicated antidi-
abetic and hypoglycaemic activities of the leaves and roots (Okokon and 
Antia, 2007; Okokon et al., 2007a). Other activities of the leaves 
include; in vitro and in vivo antimalarial (Clarkson et al., 2004; Okokon 
et al., 2007b, 2017), anti-inflammatory, analgesic (Okokon et al., 2006), 
cytotoxic, immunomodulatory and antileishmanial (Okokon et al., 
2013) and antidepressant (Okokon et al., 2016). Phytochemical con-
stituents of the leaf extract identified through various screening and 
analytical methods have been reported (Okokon et al., 2006; Okokon 
et al., 2013). Here, we report the antihyperglycaemic and hypolipidemic 
potentials of the solvent leaf fractions of Setaria megaphylla in 
alloxan-induced diabetic rats, and further isolation and identification of 
phytochemicals in these fractions. 
Materials and methods 
Plant material and extraction 
Fresh leaves of the plant were collected from Akwa Anwa forest, 
Uruan in Akwa Ibom State, Nigeria in August 2020 and identified by a 
taxonomist in the Department of Botany, University of Uyo, Uyo. A 
voucher specimen (UUPH. 221 d) of the plant was deposited at her-
barium of Department of Pharmacognosy and Natural Medicine, Uni-
versity of Uyo, Uyo. The leaves were washed, chopped into pieces, dried 
and powdered. The powder (1.5 kg) was successively and gradiently 
macerated in 7.5 L of each of these solvents at room temperature (28 ±
2 ◦C) for 72 h; n-hexane, dichloromethane (DCM), ethyl acetate (EA) and 
methanol to give corresponding their fractions. The liquid filtrates ob-
tained were concentrated to dryness at 40 ◦C using rotary evaporator 
and these were preserved in a desicator until used for the proposed 
experiments. 
Purification of compounds from dichloromethane and ethyl acetate 
fractions of Setaria megaphylla 
Dichloromethane and ethyl acetate fractions (15 g) found to be 
active during the experiment were bulked and subjected to silica gel 
column chromatography (Merck, 60–120 mesh) and gradient-eluted 
with n-hexane containing increasing quantity of dichloromethane, fol-
lowed by increasing quantity of ethyl acetate and methanol. Eluates (20 
mL each) were collected, monitored on silica thin layer chromatography 
(TLC) plates (Merck, Germany) in hexane: DCM: EA (2:1:1) using 
vanillin-sulphuric acid as spray reagent. Fifty-one fractions were ob-
tained and bulked together based on their similar TLC characteristics (Rf 
values, color reaction with spray reagents) to give four semi-pure resi-
dues coded F1–F4. F2 was further purified using preparative TLC; 
carefully dissolved in dichloromethane and applied across the coated 
silica gel plate (20 × 20 cm, 0.25 mm) using a micro-Pasteur pipette 
(Simax, India) 1 cm above the bottom edge of the plate. The plates were 
developed using n-hexane: dichloromethane (4:1) solvent system in a 
Chromatank (USA). The chromatogram obtained showed two distinctly 
resolved layers which were carefully scrapped, separated, filtered and 
concentrated in vacuo. Further TLC evaluations indicated a single spot in 
each layer which were denoted X1 (10 mg) and X16/17 (8 mg). F3 on 
further purification with preparative TLC using hexane and dichloro-
methane (1:4) yielded one pure compound N15 (10 mg). Purification of 
F4 with preparative TLC using hexane and DCM (4:1) produced a pure 
compound PJ3 (8 mg). This was filtered and concentrated to give a 
white crystalline compound. The chemical structures of isolated pure 
compounds were elucidated using spectroscopic analyses. 
Animals 
Wistar rats (males and females) used for these experiments were 
obtained from Animal house in University of Uyo. The animals were 
accommodated in standard plastic cages and maintained on pelleted 
Feed (Guinea Feed) and water ad libitum. Permission and approval for 
animal studies were obtained from College of Health Sciences Animal 
Ethics committee, University of Uyo (UU/CHS/AE/21/024). 
Induction of experimental diabetes using alloxan monohydrate 
Intraperitoneal injection of freshly prepared alloxan monohydrate 
solution (150 mg/kg i.p) in ice cold 0.9% saline (NaCl solution), was 
used to induce diabetes in overnight fasted forty (40) Wistar rats (males 
and females) weighing (140–160 g). Immediately after the induction, 2 
mL of 5% dextrose solution was orally administered to the animals to 
reduce the effect of initial hypoglycaemia (Okokon and Nyong, 2018). 
Rats with moderate diabetes, (i.e. with blood glucose levels of 200 
mg/dL and above), after a post-induction rest period of 72 h, which was 
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allowed for the diabetes to be fully developed (Lenzen, 2008) were 
considered diabetic and selected for the experiments. 
The sample size for the study was calculated using resource equation 
method of Festing (2006) and the diabetic animals were divided into 6 
(six) treatment groups of 6 rats each. Based on determined median lethal 
dose (LD50) of 2.4 ± 0.5 g/kg, (Okokon et al., al.,2006), the rats were 
treated with 200 mg/kg/day of respective solvent fractions of 
S. megaphylla leaf orally for 14 days as follows; group 1 was given 10 
mL/kg/day of normal saline, group 2, 5 mg/kg/day of glibenclamide, 
group 3 – 6 were respectively administered 200 mg/kg/day of n-hexane, 
dichloromethane, ethyl acetate and methanol fractions of S. megaphylla 
leaf. 
Assessment of oral glucose tolerance in treated diabetic rats 
Oral glucose tolerance test (OGTT) was evaluated in a group of 36 
diabetic rats induced with diabetes using alloxan as stated above. After 
confirmation and selection of the diabetic rats on the 3rd day, the rats 
were fasted for 24 h but allowed free access to water. After which the 
animals were weighed and randomised into 6 groups of 6 rats each. The 
basal Blood glucose levels (BGL) of the animals were determined by tail- 
tipping method using digital Glucometer. Thereafter, the diabetic rats 
were orally administered with 200 mg/kg of the respective solvent 
fractions (n-hexane, dichloromethane, ethyl acetate and methanol). 
Thirty (30) min post-administration of fractions the animals were given 
oral glucose load (2 g/kg). BGL were determined at 30, 60, 90, 120 and 
180 min post glucose administration (Rabintossaporn et al., 2009; 
Okokon and Mandu, 2018). 
Determination of hypoglycemic potential of the solvent fractions of S. 
megaphylla in alloxan-induced diabetic rats 
FBG of diabetic rats were determined at hourly intervals during the 
periods of acute study, i.e. 1–3, 5 and 7 h interval, after a single dose of 
the fractions and at intervals of 1–3, 5, 7 and 14 days during prolonged 
study by “the tail-tipping method” using microprocessor digital blood 
glucometer (WHO, 1980). 
Administration of fractions and drugs were carried out at a scheduled 
time daily and the animals were fasted every evening prior to days for 
measurement of the FBG concentrations. 
Determination of the body weights changes of the treated diabetic rats 
The body weights of the experimental animals were monitored 
before and after induction of diabetes and at the end of the study 
(Day15). 
Collection of blood samples and organs 
Twenty-four (24 h) after 14 days of treatment with fractions/drugs, 
the rats were weighed and sacrificed under light diethyl ether vapor. 
Blood samples were collected by cardiac puncture into plain centrifuge 
tubes and centrifuged immediately at 1500 rpm for 15 min to separate 
the serum at room temperature to avoid haemolysis. These blood sam-
ples were used for biochemical assays. The pancreas of the diabetic rats 
used in the study were surgically removed, weighed, fixed in 10% 
formaldehyde, processed, stained using Heamatoxylin and eosin (H & E) 
method and microscopically examined under the microscope at 
magnification (X400) 
Determination of insulin and glycosylated hemoglobin levels in the diabetic 
rats 
Serum insulin levels were measured with an ultra-sensitive rat in-
sulin ELISA kit (Alpco Diagnostics) (Finlay and Dillard, 2007), while 
glycosylated hemoglobin was measured by method of Nathan et al. 
(1984). 
Determination of the effect of the solvent fractions on the lipid profile 
(Serum TG, TC, HDL, LDL, VLDL levels) of the treated diabetic rats 
Serum total cholesterol (TC), triglyceride and high density lipopro-
tein (HDL) levels of the diabetic rats were measured using Randox 
diagnostic kits, low and very low-density lipoprotein (LDL and VLDL) 
were calculated from the formula of Friedwald et al. (1972). 
Gas chromatography-Mass spectrometry (GC–MS) analysis 
GC–MS was carried out on an Agilent 7890A gas chromatograph, 
coupled with an Agilent MS model 5975C MSD with triple axis detector 
(Agilent Technologies, USA). The system was equipped with a HP5-MS 
column 5% phenyl-methylpolysiloxane, 30 m × 0.25 mm × 0.25 µm 
(Agilent Technologies, USA). The carrier gas was helium with a gas flow 
under a constant pressure of 10 psi. The injector temperature was set at 
280 ◦C. The initial oven temperature was 160 ◦C and increased to 320 ◦C 
at 10 ◦C/min, and the final temperature was held for 6 min at 320 ◦C. 
The mass spectrometer was operated in the electron ionization mode at 
70 eV. The 0.2–0.4 mg of each compounds were dissolved in CHCl3 (5 
mg/mL) (X16/17 and PJ3) or treated with N,O-bis(trimethylsilyl)tri-
fluoroacetamide (BSTFA) with 1% trimethylchlorosilane (N15) for 20 
min at room temperature before injection of 1 µL to GC–MS system 
(Aldulaimi et al., 2017). The compounds were identified by comparison 
of spectral data and fragmentation patter with reference compounds in 
the NIST 2011 database. 
Nuclear magnetic resonance (NMR) spectroscopy 
1H and 13C NMR spectra for the isolated compounds were obtained 
on a Bruker 400 and 100 MHz instrument, respectively. Chemical shifts 
were reported in δ (ppm) using the solvent CDCl3 or CDCl3 + CD3OD 
(9:1) as standard and coupling constants (J) were measured in Hertz. 
Fourier transform infrared (FT-IR) spectroscopy 
Fourier transform infrared spectrometer (Nicolet AVATAR360, 
Thermo Fisher Scientific) fitted with the attenuated total reflection 
(ATR) accessory was used to record FTIR spectra with a resolution of 4.0 
cm-1 from 4000 to 800 cm-1. 
Statistical analysis 
Data obtained from this work are expressed as MEAN ± SEM and 
were analysed statistically using one way ANOVA followed by Tukey- 
Kramer multiple comparison test using Instat Graphpad software, San 
Diego, USA. Differences between means were considered significant at 
5% level of significance ie p ≤ 0.05. 
Results 
Effect of solvent fractions on body and pancreas weights of rats 
There were considerable changes in the body weights of the treated 
and untreated alloxan-induced diabetic rats (Table 1). Treatment of the 
diabetic rats with the leaf fractions caused significant (p < 0.05–0.001) 
increases in the body weight of the diabetic rats when compared to 
control. The highest increases were recorded in EA fraction-treated 
group (9.64%), followed by hexane group (8.30%) (Table 1). Signifi-
cant (p < 0.001) decreases in the pancreas weights of the diabetic rats 
compared to control was observed following treatment of alloxan 
–induced diabetic rats with leaf fractions of S. megaphylla with the 
hexane fraction exerting the highest reduction (Table 1). 
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Effects on the FBG levels of alloxan-induced diabetic rats during acute 
treatment 
The leaf fractions, 2 h post treatment, exerted considerable re-
ductions in FBG of the diabetic rats which were significant at the 7 h (p 
< 0.05–0.001) with the dichloromethane and EA fractions-treated 
groups having the most significant (p < 0.01) reductions of FBG. The 
effect of the dichloromethane fraction was stronger than that of standard 
drug, glibenclamide (7 h) (Table 2). 
Antidiabetic activities of the leaf fractions during prolonged treatment 
The leaf fractions caused significant (p < 0.05–0.001) and sustained 
lowering of FBG levels of the diabetic rats throughout the duration of the 
study. The effect of the standard drug, glibenclamide was higher than 
that of the solvents fractions. On the last day of the study (day 14), the 
FBG levels of all the groups treated with the fractions were reduced 
significantly (p < 0.001) with EA fraction exerting the highest effect 
followed by n-hexane and dichloromethane fractions which exert com-
parable effects (Table 3). 
Effect of leaf fractions on glycosylated hemoglobin level 
There was significant (p < 0.001) reduction of Hb1Ac levels in 
fractions-treated groups with the hexane and dichloromethane groups 
exerting the highest reductions. The effect of the hexane group was more 
than that of the standard drug, glibenclamide. The hexane group was 
followed by DCM and EA groups (Fig. 1). 
Effect of leaf fractions on insulin level 
The solvent fractions treatment significantly (p < 0.05–0.01) 
increased the serum insulin levels of the respective treated groups 
relative to control. These increases were highest in the glibenclamide 
and hexane fraction treated groups. This was followed by DCM and EA 
groups (Table 2). The serum insulin level of hexane group was compa-
rable to that of the standard drug, glibenclamide (Fig. 2). 
Effect of solvents fractions on oral glucose tolerance test (OGTT) 
Table 2 shows the effect of different solvent fractions on oral glucose 
tolerance test of alloxan-induced diabetic rats. The leaf fractions caused 
lowering of BGL of the diabetic rats. These reductions were significant 
(p < 0.01–0.05) when compared with control and peaked effects were 
recorded at 180 min with the various fractions producing 
(34.07–50.29%) inhibition of elevation of BGL, while the methanol 
fraction had the highest percentage inhibition of 50.98% followed by 
hexane (50.29%) and dichloromethane (43.84%) (Table 4). 
Hypolipidemic effect of leaf fractions 
The leaf fractions of S. megaphylla did not cause any significant effect 
(p > 0.05) on the levels of total cholesterol, triglyceride, HDL, LDL and 
VLDL. Although there were prominent decreases in LDL and VLDL 
levels, as well as increases in HDL levels of the fractions-treated groups, 
these changes were not significant (p > 0.05) when compared to control 
group. The standard drug, glibenclamide, caused significant (p < 0.05) 
reductions in LDL and VLDL levels (Table 5). 
Histological studies of the pancreas 
Histopathological study of pancreas of untreated diabetic rats treated 
with normal saline only (10 mL/kg) at X400 revealed distorted pancreas 
with areas of islets cells degeneration with very few cells, degranulated 
islet cells and degranulated β-cells and α-cells as well as areas of reduced 
islet cells. Pancreas of diabetic rats treated with glibenclamide and leaf 
fractions revealed some normal areas though with few areas of reduced 
islet cells of Langerhans than normal, degranulated or degenerated cell, 
thereby showing a significant protective effect (Fig. 3). 
Identification of compounds 
Five compounds were isolated and identified using FT-IR, 1H and 13C 
NMR (Supplementary materials) and GC-MS along with comparison 
with literature data as 1-triacontanal, 1-triacontanol, 1-dotriacontanol, 
1-triacontyl cerotate, and stigmasterol (Fig. 4). These compounds are 
reported for the first time from S. megaphylla. 
1-Triacontanal (X16/17), white powder. IR (ATR, νmax, cm− 1): 
2921, 2854, 1726, 1479, 1461. 1H NMR (400 MHz, CDCl3, δ, ppm), δH 
9.70 (1H, t, J = 1.83 Hz, H-1), 2.41 (2H, td, J = 7.34, 1.83 Hz, H-2), 1.63 
(2H, m, H-3), 1.25 (16H, brs), 0.88 (3H, t, J = 7.0 Hz, H-30); 13C NMR 
(100 MHz, CDCl3, δ, ppm): 14.11 (C-30), 22.10 (C-29), 22.69 (C-28), 
29.18 (C-27), 29.36 (C-26), 29.43 (C-25), 29.59 (C-4), 29.70 (C-(5–24)), 
31.93 (C-3), 43.92 (C-2), 202.95 (C-1). GC–MS (Rt, 17.918 min). m/z 
(relative%): 418.4 [M - H2O]+ (10), 268.1 (5), 147.0 (5), 96 (50), 82 
(60), 71.1 (95), 57.1 (100). GC–MS was consistent with data reported by 
Tulloch. (1987). The NMR data of 1-triacontanal were first reported. 
1-Triacontanol and 1-Dotriacontanol (ratio 1:3 by GC–MS, N15), 
Table 1 
Effect of leaf fractions of Setaria megaphylla on body and pancreas weights of 
diabetic rats.  
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4.50 0.58 ± 0.03 
a 
Data are expressed as MEAN ± SEM, Significant at ap < 0.001, when compared 
to control. (n = 6). 
Table 2 
Antidiabetic effect of leaf fractions of Setaria megaphylla on BGL of alloxan- induced diabetic rats during acute study.  
Treatment Dose Blood glucose level mg/dl in hours  
mg/kg 0 hr 1 hr 2 hr 3 hr 5 hr 7 hr 
Control normal saline 10 mL/kg 342.0 ± 47.60 243.0 ± 49.56 243.0 ± 2.94 248.66 ± 57.56 312.6 ± 65.59 326.22 ± 45.28 
Glibenclamide 10 344.0 ± 87.55 272.6 ± 87.41 203.3 ± 75.76 192.6 ± 55.36 171.3 ± 64.86 184.3 ± 61.18 c 
n-hexane fraction 200 334.6 ± 58.85 242.0 ± 42.93 198.6 ± 40.20 234.6 ± 57.81 273.0 ± 71.93 275.5 ± 44.23c 
Dichloromethane fraction 200 314.3 ± 77.62 202.33±68.00 182.0 ± 58.34 154.33 ± 42.55 156.6 ± 64.87a 113.33 ± 13.77c 
Ethyl acetate fraction 200 301.0 ± 72.38 217.3 ± 70.33 187.6 ± 59.53 170.33 ± 57.62 188.0 ± 76.70 186.2 ± 45.23c 
Methanol fraction 200 319.6 ± 87.18 276.0 ± 77.39 233.33 ± 77.28 214.33 ± 92.96 230.6 ± 84.76 226.7 ± 65.33c 
Data are expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6). 
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white powder, FT-IR (ATR, νmax, cm− 1): 3275, 2918, 2854, 1467, 1064. 
1H NMR (400 MHz, CDCl3+CH3OD (9:1)), δH 0.80 (t, J = 7.0 Hz, 3H), 
1.22 (brs, 54–58 H), 1.50 (2H, m), 3.60 (t, J = 5.0 Hz, 2H); 13C NMR 
(100 MHz, CDCl3+CH3OD (9:1)), δ: 62.62 (C-1), 32.56 (C-2), 31.86 (C- 
3), 29.62 (C-4), 29.56 (20C and 22C, C-5–25 and 5–27), 29.40, 29.28, 
25.70, 22.61, 13.98. GC–MS, TMSi-Triacontanol: m/z (Relative%): 
595.5 [M-15]+ (100), 75 (35), 57.0 (40), 43.0 (35). TMSi- 
Dotriacontanol: m/z (relative %): 523.6 [M-15]+ (100), 75 (35), 57.0 
(40), 43.0 (35). These NMR data are in agreement with those reported 
for 1-triacontanol (Mahmuod et al., 2021), and 1-dotriacontanol 
(Parmer et al., 1998). 
1-Triacontyl cerotate (X1). White solid, IR (ATR, νmax, cm− 1): 2925, 
2853, 1743, 1471, 1175; 1H NMR (400 MHz, CDCl3) δ: 4.05 (t, J = 6.8 
Hz, 2H, -CH2O), 2.30 (t, J = 7.0 Hz, 2H, -CH2CO), 1.61 (quin, J = 7.0 Hz, 
4H, -CH2CH2O and –CH2CH2CO), 1.33–1.24 (m, 98 H, 49 x CH2), 0.88 (t, 
J = 7.0 Hz, 6H, 2 x CH3); 13C NMR (100 MHz, CDCl3) δ 14.12, 22.70, 
25.06, 25.96, 28.68, 29.18, 29.27, 29.37, 29.49, 29.54, 29.62, 29.67, 
29.71, 31.94, 34.44 (CH2CO), 64.41 (O–CH2), 174.62 (COO). FT-IR and 
NMR data are consistent with reported data (Snehunsu et al., al.,2015). 
Stigmasterol ((24S)− 5,22-Stigmastadien-3β-ol, PJ3); white pow-
der. FT-IR (ATR, νmax, cm− 1): 2918, 2851, 1732, 1479, 1290. C29H48O, 
MW= 412.37. 1H NMR (400 MHz, CDCl3) δ: 0.69 (3H, d, J = 7.3 Hz, 
CH3–21), 0.81 (3H, t, J = 7.0, CH3–29), 0.90 (3H, d, J = 6.4 Hz, 
CH3–26), 1.01 (3H, d, J = 7.5 Hz, CH3–27), 1.25 (3H, s, CH3–18), 3.53 
(1H, m, H-3), 5.02 (dd, 1H, J = 8.6, 15.0 Hz, H-22), 5.16 (1H, dd, J =
6.6, 15.2 Hz, H-23) and 5.34 (1H, d, J = 4.9 Hz, H-6). 13C NMR (100 
MHz, CDCl3) δ: 140.77 (C-5), 138.32 (C-22), 129.30 (C-23), 121.72 (C- 
6), 71.84 (C-3), 56.89, 55.99, 50.19, 42.33, 40.49, 39.70, 37.28, 36.53, 
31.92, 31.69,29.71, 28.92, 25.41, 24.38, 21.22 (C-21), 21.09 (C27), 
19.41 (C-19), 18.99 (C-26), 12.25 (C-29), 12.06 (C-18). GC–MS (Rt, 
17.813 min), m/z (%): 412.2 [M]+(25), 351.3 (5), 300.1 ((8), 255.2 
(20), 213.1 (8), 145.0 (25), 105.0 (40), 55. 0 (100). NMR data are 
consistent with those reported (Chen et al., 2021). 
Discussion 
Diabetes mellitus, a chronic metabolic disorder, is reportedly asso-
ciated with increased generation of free radicals especially reactive 
Table 3 
Antidiabetic effect of solvent leaf fractions of Setaria megaphylla on blood glucose level of alloxan- induced diabetic rats during prolonged study.  
Treatment Dose Blood glucose level mg/dl in hours  
mg/kg 0 hr 24 hr 3rd day 5th day 7th day 10th day 14th day 
Control normal saline 10 mg/ml 342.0 ± 47.60 320.0 ± 52.15 312.6 ± 65.59 206.33±27.84 196.66±34.78 176.3 ± 10.13 145.3 ± 22.78 
Glibenclamide 10 344.0 ± 87.55 325.6 ± 52.44 159.3 ± 5.34 c 85.6 ± 3.52b 76.0 ± 6.92c 74.0 ± 6.65c 61.3 ± 6.36c 
n-hexane fraction 200 334.6 ± 58.85 346.0 ± 86.52 148.5 ± 9.20c 133.3 ± 4.91c 73.0 ± 2.30c 79.66 ± 7.21c 78.0 ± 8.08c 
Dichloromethane fraction 200 314.3 ± 77.62 184.3 ± 40.53 123.0 ± 5.94c 118.0 ± 4.04c 94.66 ± 6.00c 80.00 ± 4.93c 77.66 ± 4.33c 
Ethyl acetate fraction 200 301.0 ± 72.38 248.3 ± 90.03 134.0 ± 4.00c 123.6 ± 2.60c 90.33 ± 2.02c 92.33 ± 21.75c 90.66 ± 2.99c 
Methanol fraction 200 319.6 ± 87.18 354.3 ± 74.46 143.0 ± 9.57 190.3 ± 4.57 83.66±7.42 77.0 ± 10.97c 70.66 ± 8.19c 
Data is expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6). 
Fig. 1. Effect of solvent leaf fractions of Setaria megaphylla on glycosylated hemoglobin concentration of alloxan-induced diabetic rats. Data is expressed as MEAN ±
SEM. Significant at *p < 0.05, **p < 0.01, ***p < 0.001, when compared to control. (n = 6). 
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oxygen species (ROS) (Okutana et al., 2005; Papachristoforou et al., 
2020). Alloxan, which was used to induce diabetes in this study is re-
ported to be biotransformed to dialuric acid with accompanying gen-
eration of free radicals (Mathews and Leiter, 1999) and subsequently, 
partial destruction of pancreatic β-cells of islet of Langerhans (Abdel--
Barry et al., 1997). This reduces insulin level resulting in type 2 diabetes 
mellitus (Ighodaro et al., 2017), with some remnant pancreatic β-cells 
having insulin producing potentials as observed in a study with hypo-
glycemic agents like sulphonylureas in alloxan-induced diabetic rats 
(Subramoniam et al., 1996). The insulin deficiency resultantly stimu-
lates lipolysis in adipose tissues and gives rise to hyperlipidemia 
(Ahmad et al., 2014). 
In this study, S. megaphylla leaf fractions demonstrated sustained 
significant antidiabetic activities during acute and prolonged studies 
with dichloromethane, ethyl acetate and n-hexane fractions exerting 
prominent activities. The FBG levels of the treated diabetic rats were 
significantly reduced when compared to those of untreated diabetic rats 
(control). The antidiabetic results observed in this study corroborate 
those of previous reports (Okokon and Antia, 2007; Okokon et al., 
2007a). Thus, confirming and validating the antidiabetic potentials of 
this plant in ethnomedicine. 
Diabetes mellitus causes body glucose regulatory processes to be 
compromised leading to chronic hyperglycemia (Champe et al., 2005). 
The observed reduced FBG of diabetic rats following treatment with the 
leaf fractions suggests blood glucose lowering potentials probably 
through insulin secretion stimulation as was observed in this study. 
The solvents fractions were observed to cause elevation of serum 
insulin levels of the diabetic rats with n-hexane fraction producing the 
highest effect followed by DCM fraction. These fractions were observed 
to offer considerable protection to the pancreas of the diabetic rats and 
may account for the high insulin levels of the groups. This result suggests 
insulin secretion stimulatory potential as well as recovery activities of 
injured β-cells in alloxan-induced diabetic rats. These effects may have 
resulted from the antioxidative stress activities of the fractions as re-
ported earlier by Okokon et al., al.(2013), and 1-triacontyl cerotate 
(Snehunsu et al., 2015), as well as pancreatic cell stimulatory effect of 
stigmasterol which is reported to increase serum insulin levels in dia-
betic rats (Nualkaew et al., 2015), probably through regeneration of 
Fig. 2. Effect of solvent leaf fractions of Setaria megaphylla on insulin levels of alloxan-induced diabetic rats. Data is expressed as MEAN ± SEM. Significant at *p <
0.05, **p < 0.01, ***p < 0.001, when compared to control. (n = 6). 
Table 4 
Effect of solvent leaf fractions of Setaria megaphylla on Oral glucose tolerance of diabetic rats.  
Treatment Dose Blood glucose level (mg/dL) in min  
mg/kg 0 min 30 min 60 min 120 min 180 min 
Control normal saline – 154.18 ± 44.68 293.9 ± 33.24(90.62) 254.54 ± 33.68(65.09) 215.94 ± 39.36(40.05) 192.8 ± 12.96(25.04) 
Glibenclamide 10 170.28 ± 15.48 135.0 ± 21.42(20.71) 97.2 ± 11.80(42.91) 67.14 ± 9.00(60.57) 69.48 ± 11.52(59.19) 
n-hexane fraction 200 176.0 ± 51.22 180.8 ± 55.76(2.72) 91.8 ± 13.60(47.84) 97.2 ± 12.80(44.77) 87.48 ± 14.16(50.29) 
Dichloromethane fraction 200 151.7 ± 2.16 283.14 ± 24.48(86.61) 151.2 ± 8.46(0.32) 99.0 ± 9.36(34.73) 85.18 ± 5.04(43.84) 
Ethyl acetate fraction 200 174.74 ± 48.78 139.68 ± 24.48(20.06) 137.88 ± 15.22(21.09) 122.9 ± 9.90(29.66) 115.2 ± 10.08(34.07) 
methanol fraction 200 183.6 ± 44.10 185.4 ± 44.46(0.98) 117.54 ± 11.70(35.98) 86.94 ± 19.0 (52.64) 90.0 ± 8.10(50.98) 
Data is expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6). Values in parenthesis represent% inhibition of 
elevation of blood glucose calculated relative to 0 min. 
Table 5 
Effect of solvent leaf fractions of Setaria megaphylla on lipid profile of alloxan-induced diabetic rats.  
Treatment Dose mg/kg Total cholesterol (mMol/L) Triglyceride (mMol/L) HDL-C (mMol/L) LDL-C (mMol/L) VLDL (mMol/L) 
Control 10 mL/kg 2.70 ± 0.05 1.47 ± 0.08 1.81 ± 0.08 1.55 ± 0.09 0.67 ± 0.04 
Glibenclamide 10 2.20 ± 0.11 1.02 ± 0.11a 1.39 ± 0.12 1.27 ± 0.03 0.46 ± 0.04a 
n-hexane fraction 200 2.50 ± 0.12 1.41 ± 0.03 1.70 ± 0.25 1.46 ± 0.08 0.63 ± 0.01 
Dichloromethane fraction 200 2.70 ± 0.05 1.45 ± 0.05 1.87 ± 0.06 1.49 ± 0.11 0.65 ± 0.02 
Ethyl acetate fraction 200 2.90 ± 0.05 1.58 ± 0.10c 2.17 ± 0.01 1.47 ± 0.03 0.71 ± 0.04 
Methanol fraction 200 2.66 ± 0.08 1.50 ± 0.09 1.95 ± 0.24 1.38 ± 0.15 0.67 ± 0.04 
Data is expressed as MEAN ± SEM, Significant at ap < 0.05, bp < 0.01, cp < 0.001, when compared to control. (n = 6). 
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pancreatic β-cells. The presence of these compounds and earlier reported 
compounds (Okokon et al., 2007b, 2013, 2017; Udobang et al., 2017) in 
the fractions must have offered protection to the pancreas and β-cells 
against the effect of alloxan as observed in the histopathology which 
could have been responsible for the high insulin level. Thus, this ex-
plains the observed pancreas protection potential. 
The solvent fractions were found to considerably reduced FBG levels 
of treated diabetic rats during oral glucose tolerance test (OGTT). Oral 
glucose tolerance test measures the body’s ability to use glucose, the 
main source of energy (Gold, 1970). Lowering of BGL effect was 
observed post administration of the solvent fractions with methanol and 
hexane fractions exerting the highest inhibition of BGL increases. This 
may be due to the activities of phytochemicals present in the solvent 
fraction as earlier reported (Okokon et al., 2006, 2013). Blood glucose 
level after glucose loading is dependent on insulin secretion, glucose 
utilization, intestinal absorption and intestinal motility (Peungvicha 
et al., 1996), alternative mechanism by the respective fractions could 
have involved insulin secretion stimulation, glucose utilization and in-
hibition of intestinal absorption and intestinal motility. Naveen and 
Baskaran (2018) had reported that the possible modes of natural prod-
ucts action in glycemic control include stimulation of glucose uptake by 
tissues, inhibition of intestinal glucose absorption, increased glycogen 
synthesis, inhibition of dipeptidyl peptidase-IV (DPP-IV), among others. 
In this study, the fractions were observed to improved glucose 
tolerance which could be attributable to potentiation of the insulin effect 
on the plasma glucose through increased pancreatic insulin secretion 
from existing β-cells or its release from bound insulin as was observed in 
this study. This could have also resulted from the inhibitory potentials of 
the leaf fractions on α-amylase and α-glucosidase activities as reported 
earlier by Okokon et al. (2021), thereby inhibiting glucose absorption 
from the intestines, in addition to insulin secretion stimulation in 
response to glucose load and increased peripheral utilization of glucose 
which are the probable mechanisms of antidiabetic action (Andriko-
poulos et al., 2008; Regginato et al., 2021). 
In uncontrolled diabetes, high level of glycosylation of some proteins 
including hemoglobin occurs, contributing to long-term complications 
of diabetes (Latha and Pari, 2004). Hb1Ac level usually indicates gly-
cemic control (Daisy and Rajathi, 2009) and significant lowering of 
Hb1Ac levels of diabetic rats by the leaf fractions indicates controlled 
blood glucose level especially in hexane and dichloromethane 
fractions-treated groups. However, high Hb1Ac levels with corre-
sponding increased plasma glucose levels were observed in untreated 
diabetic rats. These results corroborate the findings of previous work 
(Adeneye and Adeyemi, 2009) and confirm antidiabetic activity of leaf 
Fig. 3. Histological sections of pancreas of alloxan-induced diabetic rats treated with normal saline (control) 10 mL/kg(1), glibenclamide 10 mg/kg bw (2), n-hexane 
fraction 200 mg/kg bw (3), dichloromethane fraction 200 mg/kg bw (4), ethyl acetate fraction 200 mg/kg bw(5), methanol fraction 200 mg/kg bw(6) at magni-
fication B(x400), stained with H&E method. Keys: Pancreastic acini (PA), Pancreatic Islets (PI), Pancreastic degeneration (PD). 
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fractions of S. megaphylla via insulin secretion stimulation, resulting in 
lowering of BGL and HbA1c levels. 
Phytochemical screening of the leaf extract revealed the presence of 
saponins, tannins, flavonoids, alkaloids and terpenes (Okokon et al., 
2007). Also, previous GC-MS analysis of the n-hexane fraction of the leaf 
revealed the presence of (Z,Z,Z)-8,11,14-eicosatrienoic acid, phthalic 
acid, diisooctyl ester, vitamin E, ᵞ-elemene, urs-12-ene, bicyclogerma-
crene, α-muurolene, germacrene-A, and guaiol among others (Okokon 
et al., 2013), while GC-MS analysis of ethyl acetate leaf fraction revealed 
the presence of (E)-β-ocimene, p-metha-1(7),8-diene, (3a)-D:A-friedoo-
leannan-3-ol,stigmastone-3,6‑dione(5a), bicyclo[2.2.1] heptan-2-ol, 4, 
7,7-trimethyl, p-cymene (Okokon et al., 2017). Borneol, astaxanthin, 
α-terpineol, terpinen-4-ol, β-cis-bergamotene, citronellol, germacrene D 
among others were reported in dichloromethane fraction and 3-methyl--
undecane, hexadecanoic acid, 1,2-benzene dicarboxylic acid, isodecyl 
octyl ester, carvacrol, linanlool, camphor, borneol, menthofuran, men-
thone, α-terpineol, and α-eudesmol were found in n-butanol fraction 
(Udobang et al., 2017). 
In this study, additional compounds including 1-triacontanal, 1-tri-
acontanol, 1-dotriacontanol, 1-triacontyl cerotate, and stigmasterol 
were isolated and identified. Some of these phytochemicals in these 
fractions may in part be responsible for the observed activities of these 
fractions either singly or in synergy. Several plants rich in terpenes, such 
as sesquiterpenes and monoterpenes as found in this leaf fractions have 
been shown to have an effect on blood glucose levels (Alam et al., 2018; 
Belhadj et al., 2018; Ding et al., 2018) by stimulating insulin secretion 
and glucose uptake, improving glycogen synthesis and inhibiting 
α-glucosidase (Zhao et al., 2012; Naveen and Baskaran, 2018). Ac-
cording to Brahmachari (2011), flavonoids also exhibit glycaemic con-
trol and also could regulate the rate-determining enzymes vital for 
metabolic pathways of carbohydrate. Similarly, several studies have 
shown that ß-sitosterol, stigmasterol, betulin, ergost-8(14)-en-3-ol, 
n-hexadecanoic acid, and palmitic acid exert hypoglycemic effects by 
reducing the absorptions of cholesterol from the gut ((Rajasekaran et al., 
2006); Gosh et al., 2014) and their presence in these fractions could 
likely be responsible for the observed antidiabetic activity 
Hyperglycemia and associated diabetic dyslipidemia lead to several 
comorbidities including macro-and microvascular damage (Naveen and 
Baskaran, 2018). Elevated blood glucose levels equally gives rise to low 
levels of HDL cholesterol and escalation of LDL cholesterol, thus 
increasing risk of coronary heart diseases (Sudasinghe and Peiris, 2018). 
Additionally, stimulation of catabolic activity and increased mobiliza-
tion of free fatty acids from peripheral deposits by diabetic condition as 
well as lipolytic action of hormones and inhibition of hormone sensitive 
lipase production by insulin result in elevated lipid levels, thereby, 
increasing the risk of myocardial dysfunction (Rojop et al., 2012). 
Therefore, both diabetes and lipid levels must be managed properly to 
achieve a satisfactory treatment outcome. The leaf fractions were found 
to have insignificant lowering effect on total cholesterol, TG, VLDL and 
LDL levels of the diabetic rats and considerably increased the level of 
HDL –cholesterol in the diabetic rats. The administration of the fractions 
may have partly increased glucose utiization, thereby suppressing fats 
mobilization and lipolysis involving plasma lipoprotein lipase, though 
not significantly (BenKhedher et al., 2018). 
Plants sterol such as stigmasterol present in the dichloromethane 
fraction exerts antihyperlipidemic activity through different mecha-
nisms to inhibit the absorption of cholesterol from the gut (Batta et al., 
2006). The antihyperlipidemic effects observed in this study may have 
resulted from the activities of this and other phytochemical compounds. 
Body weight loss which is due to increased muscle wasting and loss 
of tissue proteins is common in diabetic rats (Shirwaikar et al., 2005). 
Treatment with the leaf fractions especially ethyl acetate and hexane 
fractions, remedied this situation perhaps due to the chemical constit-
uents of these fractions which have the ability to reduce hyperglycaemia 
by increased glucose metabolism, inhibition of α-amylase and α-gluco-
sidase enzymes, and protein synthesis stimulation thereby suppressing 
muscle wasting through reversal of gluconeogenesis (Mestry et al., 
2017). 
Alloxan monohydrate has been reported to cause various injuries to 
the pancreas which results in partial destruction of pancreatic β-cells of 
islet of Langerhans (Abdel-Barry et al., 1997). The pancreas of untreated 
diabetic rats were observed to have areas of islets cell degeneration, 
degranulated islet, degranulated β- and α- cells as well as reduced islet 
cells among others. These pathologic features were not prominent in the 
Fig. 4. Chemical structures of isolated and identified compounds from S. megaphylla.  
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leaf fractions treated groups, suggesting regenerative effect of the 
extract. The phytoconstituents in these leaf fractions such as stigmas-
terol, hexadecanoic acid and 1-triacontanol cerotate among others, 
through their antioxidative effect, could have caused the regeneration of 
the pancreas and increased level of insulin in treated diabetic rats in this 
study resulting in hypoglycaemic activity. The protection maybe due to 
the free radical scavenging potentials of the leaf fractions as reported by 
Okokon et al.,(2013) and recently by Umana (2021) which revealed 
strong antioxidant potentials of the hexane and ethyl acetate fractions of 
the leaf extract in the various in vitro models. This activity inherent in 
the leaf extract/fractions could have counteracted the vast free radicals 
generated by alloxan and the diabetic condition thereby leading to the 
observed antidiabetic and pancreas protective effects in this study. 
However, this study could not determined the quantities of these 
identified and isolated compounds in the fractions, which is necessary 
for the standardization of the extract/fractions in order to be used 
effectively and safely nor established the antioxidant and antidiabetic 
activities of the isolated compounds. These were the limitations of this 
study which further study has been recommended to be carried out on 
the leaf extract. 
Conclusion 
The results of this study show that the leaf fractions of S. megaphylla 
possess antidiabetic, hypolipidemic and pancreas protective potentials, 
which may be partially attributed to the identified compounds from this 
plant. 
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